CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- DEF 14A Proxy Proxy Statement
- SC 13D Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Item 5 · Item 7
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 POS Other Post-effective Amendment
- 10-K Report Annual Report
- 424B5 Offering Prospectus
- 8-K Event Item 5 · Item 7
Page 68 of 77 · 1,539 filings